ORBIMED ADVISORS LLC 13D/13G Filings for Janux Therapeutics, Inc. (JANX)

ORBIMED ADVISORS LLC 13D and 13G filings for Janux Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-08-09
4:09 pm
Sale		 2024-07-31 13D Janux Therapeutics, Inc.
JANX		 ORBIMED ADVISORS LLC 1,965,266
3.800%		 -684,198decrease
(-25.82%)		 Filing
2021-12-17
5:08 pm
Purchase		 2021-12-16 13D Janux Therapeutics, Inc.
JANX		 ORBIMED ADVISORS LLC 2,649,464
6.400%		 2,649,464increase
(New Position)		 Filing